Literature DB >> 15494483

Vaccination in humans generates broad T cell cytokine responses.

Stephen C De Rosa1, Fabien X Lu, Joanne Yu, Stephen P Perfetto, Judith Falloon, Susan Moser, Thomas G Evans, Richard Koup, Christopher J Miller, Mario Roederer.   

Abstract

In recent years, the quantification of T cell responses to pathogens or immunogens has become a common tool in the evaluation of disease pathogenesis or vaccine immunogenicity. Such measurements are usually limited to enumerating IFN-gamma-producing cells after ex vivo stimulation with Ag, but little is known about the phenotype or complete functional repertoire of the Ag-specific cells. We used 12-color flow cytometry to characterize Ag-specific T cells elicited by vaccines or natural infection to determine lineage and differentiation status as well as the capacity to produce four cytokines (IFN-gamma, TNF-alpha, IL-2, and IL-4) and a chemokine (MIP1beta). As expected, responding cells had a typical memory phenotype; however, the cytokine profiles associated with the responses were highly complex. The pattern of cytokine coexpression in response to specific Ags was a skewed subset of the complete repertoire (revealed by polyclonal stimulation). We found significant differences in the patterns of cytokines elicited by vaccination (where IFN-gamma was by far a subdominant response) vs natural infection; in addition, there was fairly significant intersubject variation. Our findings illustrate the limitation of the evaluation of immune responses using single functional measurements (such as IFN-gamma); in fact, it is likely that sensitive evaluation of Ag-specific T cells will require the coordinate measurement of several cytokines. The presence and variability of these complex response profiles introduce the possibility that selective functional expression patterns may provide correlates for vaccine efficacy or disease progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494483     DOI: 10.4049/jimmunol.173.9.5372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  93 in total

Review 1.  Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.

Authors:  George Makedonas; Michael R Betts
Journal:  Springer Semin Immunopathol       Date:  2006-08-25

2.  Inhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426.

Authors:  Kaboutar Babaahmady; Wulf Oehlmann; Mahavir Singh; Thomas Lehner
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

Authors:  Helen Horton; Evan P Thomas; Jason A Stucky; Ian Frank; Zoe Moodie; Yunda Huang; Ya-Lin Chiu; M Juliana McElrath; Stephen C De Rosa
Journal:  J Immunol Methods       Date:  2007-04-03       Impact factor: 2.303

4.  MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

Authors:  Barbara C Baudner; Vanessa Ronconi; Daniele Casini; Marco Tortoli; Jina Kazzaz; Manmohan Singh; Lynn D Hawkins; Andreas Wack; Derek T O'Hagan
Journal:  Pharm Res       Date:  2009-03-03       Impact factor: 4.200

5.  Mixture models for single-cell assays with applications to vaccine studies.

Authors:  Greg Finak; Andrew McDavid; Pratip Chattopadhyay; Maria Dominguez; Steve De Rosa; Mario Roederer; Raphael Gottardo
Journal:  Biostatistics       Date:  2013-07-24       Impact factor: 5.899

6.  Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Authors:  Shalyn C Clute; Levi B Watkin; Markus Cornberg; Yuri N Naumov; John L Sullivan; Katherine Luzuriaga; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 7.  Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.

Authors:  Fadi Saade; Stacey Ann Gorski; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

8.  Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.

Authors:  Sharon Shalekoff; Stephen Meddows-Taylor; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn; Caroline T Tiemessen
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

9.  A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults.

Authors:  Xia Jin; Mark J Newman; Stephen De-Rosa; Cristine Cooper; Evan Thomas; Michael Keefer; Jonathan Fuchs; William Blattner; Brian D Livingston; Denise M McKinney; Elizabeth Noonan; Allan Decamp; Olivier D Defawe; Margaret Wecker
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

10.  Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.

Authors:  S Pichyangkul; U Kum-Arb; K Yongvanitchit; A Limsalakpetch; M Gettayacamin; D E Lanar; L A Ware; V A Stewart; D G Heppner; P Mettens; J D Cohen; W R Ballou; M M Fukuda
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.